Main Diagnostic Methods for Covid-19: Integrative Review.
Ana Sara Martins de Campos,Giandra Azolini Fernandes de Souza,Renan Almeida de Jesus,Giuliana Zardeto,Guilherme Donadel,Mariana Dalmagro,Jéssica Renata de Almeida Canoff,Jaqueline Hoscheid,Odair Alberton,Daniela de Cássia Faglioni Boleta-Ceranto,Daniela Dib Gonçalves,Emerson Luiz Botelho Lourenço,Juliana Cogo
DOI: https://doi.org/10.2174/1381612828666220526113232
IF: 3.31
2022-05-29
Current Pharmaceutical Design
Abstract:Background: COVID-19 has reached more than 20 million people since its appearance in December 2019. As a result of the infection process by the Sars-CoV-2 virus, patients manifest initial symptoms easily mistaken for common flu. However, in a small group of the population, the condition may progress to pneumonia or Severe Acute Respiratory Syndrome (SARS). Objective: The objective of this study was to carry out an integrative review on laboratory and imaging diagnostics for COVID-19, in the period from 2019 to 2021. Method: Electronic databases PubMed, Google Scholar, SciELO, Virtual Library, LILACS, MEDLINE, ScienceDirect and the official website of the World Health Organization were used. Results: RT-qPCR identifies fragments of viral RNA in the initial stage of the disease since the genes E and RdRp are the most used, given the great sensitivity. Imaging and serological methods can be used as complementary exams. The main radiographic findings are reticular and ground-glass opacity patterns, reversed halo sign, mosaic attenuation, and consolidations. The antibody levels are detected after the seventh day of symptom onset. Conclusion: Caution should be exercised when interpreting the results for the diagnosis of COVID-19, since the onset of clinical symptoms and laboratory and imaging tests must be taken into account. Keywords: Diagnostic methods, COVID-19, SARS-CoV-2, coronavirus, pandemic, immunological tests, clinical imageology, serological tests.
pharmacology & pharmacy